Analyze the earnings history of Bristol-Myers Squibb using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/25/2024 | AM | BMY | Q1 | $2.05 | $1.58 | — | — | $11.34B | — | — | — | Get Alert |
02/02/2024 | AM | BMY | Q4 | $1.82 | $1.53 | $1.70 | 11.11% | $11.41B | $11.19B | $11.48B | 2.55% | Get Alert |
10/26/2023 | AM | BMY | Q3 | $1.99 | $1.76 | $2.00 | 13.64% | $11.22B | $10.97B | $10.97B | -0.04% | Get Alert |
07/27/2023 | AM | BMY | Q2 | $1.93 | $1.98 | $1.75 | -11.62% | $11.89B | $11.81B | $11.23B | -4.94% | Get Alert |
04/27/2023 | AM | BMY | Q1 | $1.96 | $1.97 | $2.05 | 4.06% | $11.65B | $11.49B | $11.34B | -1.33% | Get Alert |
02/02/2023 | AM | BMY | Q4 | $1.83 | $1.72 | $1.82 | 5.81% | $11.98B | $11.20B | $11.41B | 1.84% | Get Alert |
10/25/2022 | PM | BMY | Q3 | $2.00 | $1.83 | $1.99 | 8.74% | $11.62B | $11.19B | $11.22B | 0.25% | Get Alert |
07/27/2022 | AM | BMY | Q2 | $1.93 | $1.82 | $1.93 | 6.04% | $11.70B | $11.45B | $11.89B | 3.82% | Get Alert |
04/29/2022 | AM | BMY | Q1 | $1.74 | $1.91 | $1.96 | 2.62% | $11.07B | $11.36B | $11.65B | 2.54% | Get Alert |
02/04/2022 | AM | BMY | Q4 | $1.46 | $1.80 | $1.83 | 1.67% | $11.07B | $12.08B | $11.98B | -0.79% | Get Alert |
10/27/2021 | AM | BMY | Q3 | $1.63 | $1.92 | $2.00 | 4.17% | $10.54B | $11.58B | $11.62B | 0.38% | Get Alert |
07/28/2021 | AM | BMY | Q2 | $1.63 | $1.91 | $1.93 | 1.05% | $10.13B | $11.33B | $11.70B | 3.29% | Get Alert |
04/29/2021 | AM | BMY | Q1 | $1.72 | $1.82 | $1.74 | -4.40% | $10.78B | $11.11B | $11.07B | -0.33% | Get Alert |
02/04/2021 | AM | BMY | Q4 | $1.22 | $1.41 | $1.46 | 3.55% | $7.95B | $10.73B | $11.07B | 3.15% | Get Alert |
11/05/2020 | AM | BMY | Q3 | $1.17 | $1.49 | $1.63 | 9.40% | $6.01B | $10.33B | $10.54B | 2.03% | Get Alert |
08/06/2020 | AM | BMY | Q2 | $1.18 | $1.48 | $1.63 | 10.14% | $6.27B | $9.97B | $10.13B | 1.59% | Get Alert |
05/07/2020 | AM | BMY | Q1 | $1.10 | $1.49 | $1.72 | 15.44% | $5.92B | $10.02B | $10.78B | 7.59% | Get Alert |
02/06/2020 | AM | BMY | Q4 | $0.94 | $0.94 | $1.22 | 29.79% | $5.97B | $6.19B | $7.95B | 28.35% | Get Alert |
10/31/2019 | AM | BMY | Q3 | $1.09 | $1.07 | $1.17 | 9.35% | $5.69B | $5.90B | $6.01B | 1.81% | Get Alert |
Bristol-Myers Squibb (BMY) is scheduled to report earnings on April 25, 2024. The last reported earnings were for reported on February 2, 2024 for Q4.
The Actual EPS was $1.70, which beat the estimate of $1.53.
The Actual Revenue was $11.5B, which beat the estimate of $11.2B.
Browse earnings estimates, EPS, and revenue on all stocks.